You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 79 No. 6, June 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Pilocarpine in Counteracting Mydriasis

Lorene M. Anastasi, MD; Kenneth N. Ogle, PhD; Thomas P. Kearns, MD

Arch Ophthalmol. 1968;79(6):710-715.


Abstract

The effectiveness of 1% pilocarpine in counteracting the mydriatic effect of phenylephrine hydrochloride (Neo-Synephrine Hydrochloride), hydroxyamphetamine hydrobromide (Paredrine), tropicamide (Mydriacyl), and homatropine hydrobromide in the concentrations ordinarily used in clinical ophthalmology was studied in 15 subjects. Pupillary diameters were measured with the infrared electronic pupillograph. It was found that the mydriatic effects of the sympathomimetic drugs (phenylephrine and hydroxyamphetamine) are rapidly counteracted by pilocarpine, usually in much less than 30 minutes. However, after mydriasis with parasympatholytic drugs (tropicamide and homatropine), pilocarpine produced little effective miosis and the pupil remained dilated or semidilated for a prolonged period.



Author Affiliations

Rochester, Minn

From the sections of biophysics (Dr. Ogle) and ophthalmology (Dr. Kearns), Mayo Clinic and Foundation, and the Mayo Graduate School of Medicine (Dr. Anastasi), Rochester.

Dr. Ogle died Feb 22, 1968.


Footnotes

Submitted for publication Nov 10, 1967.

Reprint requests to Mayo Clinic, 200 First St SW, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Guide to the Isolated Dilated Pupil
Lee et al.
Arch Fam Med 1997;6:385-388.
ABSTRACT  

Counteracting the Effects of Mydriatics: Does It Benefit the Patient?
Nelson and Orton
Arch Ophthalmol 1987;105:486-489.
ABSTRACT  

The Fixed Dilated Pupil: Sudden Iridoplegia or Mydriatic Drops? A Simple Diagnostic Test
Thompson et al.
Arch Ophthalmol 1971;86:21-27.
ABSTRACT  

Pharmacology and Toxicology of Ophthalmic Drugs
Macri
Arch Ophthalmol 1969;82:707-719.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.